Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
09/2005
09/09/2005WO2005028619A3 Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
09/09/2005WO2005021708A3 Bisphosphonates for prophylaxis and therapy against bioterrorism agents
09/09/2005WO2004108889A3 Hybrid antibodies
09/09/2005WO2004106494A3 A preservative and method for preserving cells
09/09/2005WO2004096998A3 Nanoparticular tumor targeting and therapy
09/09/2005WO2004092347A3 Etalon based compact dispersion module
09/09/2005WO2004087862A3 Tak1-mediated inhibition of osteogenesis
09/09/2005WO2004085608A3 Methods for high throughput elucidation of transcriptional profiles and genome annotation
09/09/2005WO2004078925A3 Methods and compositions for treating and preventing neurodegenerative diseases
09/09/2005WO2004076635A3 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
09/08/2005US20050197785 Apparatus and methods for assessing metabolic substrate utilization
09/08/2005US20050196777 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
09/08/2005US20050196411 Immunogenic HIV compositions and related methods
09/08/2005US20050196406 Which display a passenger polypeptide on the outer surface of a biological entity; displayed passenger polypeptide is capable of interacting or binding with a given ligand
09/07/2005EP1569680A2 Treatment of diabetes
09/07/2005EP1151109B1 Fucosyl transferase gene
09/07/2005EP1025237B1 Human checkpoint kinase, hcds1, compositions and methods
09/07/2005CN1665938A Methods of detecting sequence differences
09/07/2005CN1665937A Methods and compositions for determining methylation profiles
09/01/2005WO2005080568A1 Methods and compositions for treatment or prevention of secondary ischemic injury
09/01/2005WO2005047476A3 Inhibition of retroviral replication through modulation of the host cell ubiquitylation
09/01/2005WO2005037995A3 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy
09/01/2005WO2005017113B1 Metalloproteinase gene polymorphism in copd
09/01/2005WO2004101746A3 Production of carotenoids in microorganisms
09/01/2005WO2003091417A3 Self-similar ordered microstructural arrays of amphiphilic molecules
09/01/2005US20050193434 IL-21 as a regulator of immunoglobin production
09/01/2005US20050191358 Microparticles with adsorbed polynucleotide-containing species
08/2005
08/31/2005EP1567862A2 Compositions and methods for the reversible capture of biomolecules
08/31/2005EP1567672A2 Expression profiling based on histocultures
08/31/2005CN1662663A DNA enzyme to inhibit plasminogen activator inhibitor-1
08/30/2005US6936695 Manufacture and expression of large structural genes
08/30/2005US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon
08/30/2005US6936693 Specific polypeptides, useful as nematocides
08/30/2005US6936254 Method of inducing fetal hemoglobin synthesis
08/25/2005WO2005030925A9 Microfluidic rotary flow reactor matrix
08/25/2005WO2005028615A3 Methods and compositions for detecting promoter activity and expressing fusion proteins
08/25/2005WO2005014793A3 Primary rat hepatocyte toxicity modeling
08/25/2005WO2005010154A3 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
08/25/2005WO2005007829A3 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
08/25/2005WO2005007827A3 Avian adeno-associated virus vector
08/25/2005WO2004113500A3 B7s1: an immune modulator
08/25/2005WO2004106493A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/25/2005WO2004072228A3 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
08/25/2005US20050187241 Method of inhibiting choroidal neovascularization
08/25/2005US20050186658 Chimeric metabotropic glutamate receptors and uses thereof
08/25/2005US20050186590 Nucleic acid detection method having increased sensitivity
08/25/2005US20050186589 Interspersed repetitive element RNAs as substrates, inhibitors and delivery vehicles for RNAi
08/25/2005US20050184272 Organic cooling medium and its uses
08/24/2005EP1565741A2 Inferring gene regulatory networks from time-ordered gene expression data using differential equations
08/24/2005EP1565573A1 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used
08/24/2005EP1565200A2 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
08/24/2005CN1659281A Antiviral therapy on the basis of RNA interference
08/24/2005CN1659272A Product
08/18/2005WO2005056760A3 Glycopegylated follicle stimulating hormone
08/18/2005WO2005054435A3 Methods and compositions for in vitro amplification of extrachromosomal nucleic acid
08/18/2005WO2005052123A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
08/18/2005WO2005052122A3 METHODS FOR CONTROLLING PATHOLOGICAL ANGIOGENESIS BY INHIBITION OF α6β4 INTEGRIN
08/18/2005WO2005051436A3 Method for tooth organ reconstruction
08/18/2005WO2005047487A8 Motoneuronotrophic factor gene sequences
08/18/2005WO2005047464A3 Cell culture tool and method
08/18/2005WO2005045000A3 Estrogen receptor gene variation and disease
08/18/2005WO2005044984A3 Modulators of the abc transporter family and methods for their use
08/18/2005WO2005037998A8 Methods and compositions related to a matrix chip
08/18/2005WO2005030934A3 Methods of preventing restenosis
08/18/2005WO2005028626A3 Cell culture media
08/18/2005WO2005026318A3 Methods and compositions for producing antigenic responses
08/18/2005WO2005023980A3 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development
08/18/2005WO2005021732A3 Organic cooling medium and its uses
08/18/2005WO2005019419B1 Co-detection of single polypeptide and polynucleotide molecules
08/18/2005WO2005017125A3 Method for isolation and replication of infectious human hepatitis-c virus
08/18/2005WO2005003291A3 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
08/18/2005WO2004099378A3 Automated laboratory for high-throughput biological assays and rna interference
08/18/2005WO2004094607A3 Methods of therapy and diagnosis using targeting of cells that express a human transporter-like protein
08/18/2005WO2004094597A3 Anthozoan fluorescent protein genes
08/18/2005WO2004076622A3 Regulation of gene expression by dna interference
08/18/2005WO2004076614A3 Human nucleic acid sequences obtained from prostatic carcinomas
08/18/2005WO2004072246A3 Polymerase-based protocols for the introduction of combinatorial deletions and insertions
08/18/2005WO2004048541A3 Cct6s as modifiers of the rb pathway and methods of use
08/18/2005US20050182010 Use of a nucleotide construct stably integrated in the genome of the target cells of the virus, which is able to produce a single transcript or multiple transcripts capable of forming a double-stranded RNA which inhibits replication of the virus
08/18/2005US20050181382 Mediates silencing of a target gene; lessening the base pair strength between the 5' end of the first strand and the 3' end of a second strand of the duplex as compared to the base pair strength
08/18/2005US20050180981 Human checkpoint kinase, hCDS1, compositions and methods
08/18/2005US20050180969 which binds to B lymphoblastoid cells and induces proliferation and activation of peripheral blood lymphocytes; anti-tumor effect when injected into a tumor-bearing subject
08/17/2005EP1563100A2 Displacement sandwich immuno-pcr
08/17/2005EP1563092A2 Assays and methods based on microcompetition with a foreign polynucleotide
08/17/2005EP1563070A2 2'-substituted oligomeric compounds and compositions for use in gene modulations
08/17/2005EP1562640A2 Methods for purifying radiolabelled compounds
08/17/2005EP1427830A4 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
08/17/2005CN1656380A Arrays of microparticles and methods of preparation thereof
08/16/2005US6929928 Genes encoding carotenoid compounds
08/16/2005US6929917 identifying mutant cells in a culture using two polymerase chain reaction (PCR) processes, the product of the first being used as the template of the second; first PCR is a conventional PCR and the second is an allele specific PCR (AS-PCR)
08/16/2005US6929808 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein
08/16/2005CA2098533C Carrier system against gnrh
08/11/2005WO2005040348A3 Method for two- and three-dimensional microassembly of patterns and structures
08/11/2005WO2005040346A3 Devices and methods for hematopoietic rescue or restoration
08/11/2005WO2005033287A3 Methods for identifying a biosynthetic pathway gene product
08/11/2005WO2005030929A3 Polymeric nucleic acid hybridization probes
08/11/2005WO2005010145A3 Method and compositions for detection and enumeration of genetic variations
08/11/2005WO2005001053A3 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
08/11/2005WO2004094602A3 Combinatorial surface chip compositions for selection, differentiation and propagation of cells
08/11/2005WO2004083396A3 Methods for the identification of inhibitors of porphobilinogen deaminase, bifunctional purine biosynthetic protein, and a transcription factor as antibiotics
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 100